Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Science (New York, N.Y.)|July 13, 1973
Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicityT B Strom, M R Garovoy, D B Carpenter, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1974
Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytesT B Strom, A J Sytkowski, C B Carpenter, et al.The New England Journal of Medicine|December 14, 1978
Factors contributing to the declining mortality rate in renal transplantationN L Tilney, T B Strom, G C Vineyard, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclaseT B Strom, A Deisseroth, J Morganroth, et al.The Journal of Experimental Medicine|August 1, 1973
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicityT B Strom, C B Carpenter, M R Garovoy, et al.The American Journal of Pathology|May 1, 1975
Immunologic enhancement of rat renal allografts. III. Immunopathologic lesions and rejection in long-surviving passively enhanced graftsA K Abbas, J M Corson, C B Carpenter, et al.The American Journal of Medicine|July 1, 1982
The improving utility of renal transplantation in the management of end-stage renal diseaseT B StromNephron|January 1, 1976
Secondary hyperparathyroidism in human kidney transplant recipientsP G Pletka, T B Strom, C L Hampers, et al.Journal of Clinical Immunology|July 1, 1995
Immunobiology and immunopharmacology of organ allograft rejectionM Suthanthiran, T B StromPediatric Nephrology (Berlin, Germany)|November 5, 1997
Immunoregulatory drugs: mechanistic basis for use in organ transplantationM Suthanthiran, T B StromPageof 27